Delivery Order SPE2DX22D0010-SPE2D826FAR49

AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,271.40 by the Defense Logistics Agency's Medical Supply Chain on October 28, 2025. This firm fixed-price delivery order, which is a child contract under a larger vehicle, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of October 29, 2025. The contract aligns with the company's extensive portfolio of federal medical supply contracts, through which it delivers a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities.

This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling the company to supply a vast array of products across multiple therapeutic domains to support military healthcare programs, the Defense Health Agency, the U.S. Coast Guard, and other government healthcare systems worldwide. The contract reflects the company's established capability to meet federal procurement requirements and its critical role as a pharmaceutical vendor within the defense medical supply chain.